Articles

10 pieces from Local Health Today.

BetterHelp vs. In-Person Therapy: Is Digital Mental Health Care Right for You?

The rise of platforms like BetterHelp has made therapy more accessible than ever. We compare the clinical benefits and costs of…

Compounded Semaglutide vs. Branded Ozempic: Understanding the Science, Safety, and Savings

With shortages of Wegovy and Ozempic continuing, compounded semaglutide has become a popular alternative. We explore the differ…

GoodRx vs. Manufacturer Coupons: Which Will Save You More at the Pharmacy?

Navigating the world of prescription discounts can be confusing. We compare GoodRx and manufacturer copay cards to help you fin…

Hims vs. Lemonaid: Which Telehealth Platform Is Right for Your Weight Loss Journey?

Comparing the two leading telehealth platforms for weight loss medication. We break down the pricing, provider access, and medi…

In-Home Care vs. Assisted Living: The Financial and Practical Comparison

Deciding between aging in place and moving to a facility is one of the hardest choices a family can make. We break down the mat…

Medicare Advantage Trap Signs: How to Spot a Plan That Could Cost You More

Medicare Advantage plans often promise $0 premiums and extra perks, but they can come with hidden costs and restricted care. He…

Medicare Part D Selection Guide: How to Find the Best Prescription Drug Plan

Choosing a Medicare Part D plan can feel like a gamble. We provide a step-by-step guide to evaluating formularies, tiers, and t…

Telehealth in 2026: Navigating New State-by-State Restrictions

As pandemic-era flexibilities expire, the rules for seeing a doctor online are changing. We explain the new 'cross-border&…

The GLP-1 Side-Effect Playbook: Managing Nausea, Fatigue, and 'Ozempic Face'

Weight-loss medications like Wegovy and Zepbound are powerful, but they come with a learning curve. Here is our practical guide…

Tirzepatide Cash-Pay in 2026: Pricing, Availability, and Sourcing Strategies

As Zepbound and Mounjaro become the new gold standard for weight loss, we look at the 2026 cash-pay landscape for tirzepatide a…